Neurotrophin-3 inhibits HCO3- absorption via a cAMP-dependent pathway in renal thick ascending limb

Neurotrophins are expressed in the adult kidney, but theirsignificance is unclear. We showed previously that nerve growth factor(NGF) inhibits HCO absorption in the rat medullarythick ascending limb (MTAL) via an extracellular signal-regulatedkinase (ERK)-dependent pathway. Here we examined whether otherneurotrophic factors affect MTAL HCO absorption.Brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor had no effect. In contrast, neurotrophin-3 (NT-3,0.7 nM) inhibited HCO absorption by 40%(half-maximal inhibition at ~0.4 nM). Inhibition by NT-3 was additiveto inhibition by NGF. Inhibitors of ERK activation that blockinhibition by NGF had no effect on inhibition by NT-3. In contrast,8-bromo-cAMP or forskolin pretreatment blocked inhibition by NT-3 butnot NGF. Inhibition by NT-3 was also blocked by the specific proteinkinase A (PKA) inhibitor myristoylated PKI(14-22) amide and by vasopressin, which inhibits HCO absorption via cAMP. Inhibitors of phosphatidylinositol 3-kinase orprotein kinase C did not affect NT-3-induced inhibition, but inhibitionby NT-3 was eliminated by genistein, consistent with involvement of areceptor tyrosine kinase. These results demonstrate that NT-3 inhibitsHCO absorption via a cAMP- and PKA-dependentpathway. NT-3 and NGF regulate MTAL ion transport through differentsignal transduction mechanisms. These studies establish a direct rolefor NT-3 in regulation of renal tubule transport and identify the MTALas an important target for neurotrophins, which may be involved in thecontrol of renal acid excretion.